Variable All Subjects (N=105)
Age (years)
Mean ± SD (n) 64.5 ± 8.4 (105)
Range (Min, Median, Max) (40, 64, 82)
Sex, (%) n/N
Male 74.3% (78/105)
Female 25.7% (27/105)
NYHA Class (%) n/N
Class I 5.7% (6/105)
Class II 57.1% (60/105)
Class III 37.1% (39/105)
Class IV 0.0% (0/105)
Cardiomyopathy Etiology (%) n/N
Non-ischemic 58.1% (61/105)
Ischemic 41.9% (44/105)
Prior Cardiac Interventions (%) n/N
ICD Implant 68.6% (72/105)
Valve Replacement 52.4% (55/105)
CABG 3.8% (4/105)
PCI 3.8% (4/105)
Valve Repair 1.0% (1/105)
Comorbidities (%) n/N
Hypertension 68.6% (72/105)
Hypercholesterolemia 52.4% (55/105)
Smoker 49.5% (52/105)
Diabetes Mellitus 42.9% (45/105)
Dilated Cardiomyopathy 23.8% (25/105)
Renal Disease 10.5% (11/105)
CVA 9.5% (10/105)
COPD 9.5% (10/105)
Neoplastic Disease 5.7% (6/105)
Alcoholic 3.8% (4/105
Valvular Disease 3.8% (4/105)
Cardiac Medication (%) n/N
Beta-Blockers 83.8% (88/105)
Diuretics 71.4% (75/105)
Aldosterone Antagonist 58.1% (61/105)
ACE 56.2% (59/105)
Antiplatelets 43.8% (46/105)
ARB 36.2% (38/105)
Anticoagulants 23.8% (25/105)